There’s no such thing as 'natural Ozempic.' While supplements like psyllium, berberine, and glucomannan are paraded as ...

Theratechnologies entered a definitive agreement to be acquired by Future Pak. Find out why do not expect to see THTX stock ...

A Delhi HC directive to examine unregulated use of weight loss drugs may lead to a CDSCO expert panel by mid-July, possibly ...

The country’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, the UK’s official system for ...

TMates offers a structured weight loss program built around GLP-1 therapy, created by a team of licensed healthcare ...

As demand for obesity drugs rises, questions emerge over approvals granted without India-specific safety and efficacy trials.

Explore how MitoRx’s Myo4 is showing promise in combating obesity by restoring insulin sensitivity and reducing fat.

In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

TMates Weightloss Semaglutide reviews reveal how users are losing weight with this telehealth prescription service—see if it ...

A NEW Phase 3 trial has shown that a combination therapy of cagrilintide and semaglutide (CagriSema) can lead to substantial ...

The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...